Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,461 public trials 543 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Completed

A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission

NCT02927262

Conditions
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation, Hematologic Diseases, +6 more
Locations
  • Site US10017 Gainesville, Florida, United States
  • Site US10030 Jacksonville, Florida, United States
  • Site US10012 Chicago, Illinois, United States
  • Site US10025 Syracuse, New York, United States
View all 73 locations
View Trial Details
Completed

A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

NCT04079296

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • City of Hope Duarte, California, United States
  • Memorial Healthcare System-West Pembroke Pines, Florida, United States
  • NYU Langone Health New York, United States
  • Site JP81005 Nagoya, Aichi-ken, Japan
View all 16 locations
View Trial Details
Completed

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

NCT03761914

Conditions
Acute Myelogenous Leukemia, Adnexal Diseases, Breast Diseases, +45 more
Locations
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • Innovative Clinical Research Institute (ICRI) Whittier, California, United States
  • Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
View Trial Details
Completed

A Study of the Effectiveness of Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants Ineligible for Standard Induction Therapy in Russian Federation

NCT04253314

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Moscow State budget healthcare /ID# 218569 Moscow, Russia
  • Saratov State Medical University n.a. V.I. Razumovskiy /ID# 226059 Saratov, Saratov Oblast, Russia
  • Hematology department State budgetary health care institution Volgograd region /ID# 229813 Volgograd, Volgograd Oblast, Russia
  • Regional Clinical Hospital of Irkutsk /ID# 218570 Irkutsk, Russia
View Trial Details
Completed

Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of ASP2215 in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT02181660

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Site JP00002 Aichi, Japan
  • Site JP00003 Fukuoka, Japan
  • Site JP00001 Gunma, Japan
  • Site JP00004 Tokyo, Japan
View Trial Details
Completed

A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT02236013

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Site US10003 Los Angeles, California, United States
  • Site US10013 New Haven, Connecticut, United States
  • Site US10004 Chicago, Illinois, United States
  • Site US10009 Westwood, Kansas, United States
View Trial Details

Related conditions